Your session is about to expire
← Back to Search
Dicarboxylic Acids
Azelaic Acid for Melanosis
Phase 4
Waitlist Available
Led By Valerie D Callender, MD
Research Sponsored by Callender Center for Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
The purpose of this study is to compare the safety and effectiveness of Azelaic Acid Gel to Hydroquinone Cream in the treatment of melasma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement of melasma
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Azelaic AcidExperimental Treatment1 Intervention
Group II: HydroquinoneActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Callender Center for Clinical ResearchLead Sponsor
3 Previous Clinical Trials
104 Total Patients Enrolled
Valerie D Callender, MDPrincipal InvestigatorHoward University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
3+
Why did patients apply to this trial?
I'm sure hydroquinone made things worse. I would welcome a treatment that incorporated gene mapping, an inside approach may give better clues however, the opportunity to try something promising is also a consideration.
PatientReceived 1 prior treatment
Recent research and studies
Share this study with friends
Copy Link
Messenger